Necrotizing fasciitis caused by Apophysomyces variabilis in a burn patient
Tài liệu tham khảo
Stevens, 2005, Practice guidelines for the diagnosis and management of skin and soft-tissue infections, Clin Infect Dis, 41, 1373, 10.1086/497143
Gomes, 2011, Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species, Clin Microbiol Rev, 24, 411, 10.1128/CMR.00056-10
Prakash, 2019, Global epidemiology of mucormycosis, J Fungi (Basel), 5, E26, 10.3390/jof5010026
Guarro, 2011, Apophysomyces variabilis infections in humans, Emerg Infect Dis, 17, 134, 10.3201/eid1701.101139
Prakash, 2016, The environmental source of emerging Apophysomyces variabilis infection in India, Med Mycol, 54, 567, 10.1093/mmy/myw014
Ribes, 2000, Zygomycetes in human disease, Clin Microbiol Rev, 13, 236, 10.1128/CMR.13.2.236
Misra, 1979, Apophysomyces, a new genus of the Mucorales, Mycotaxon, 8, 337
Alvarez, 2010, Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species, Rev Iberoam Micol, 27, 80, 10.1016/j.riam.2010.01.006
Bonifaz, 2014, Primary cutaneous mucormycosis produced by the new species Apophysomyce mexicanus, J Clin Microbiol, 52, 4428, 10.1128/JCM.02138-14
Chander, 2010, Primary cutaneous zygomycosis from a tertiary care centre in north-west India, Indian J Med Res, 131, 765
Chander, 2015, Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales), Rev Iberoam Micol, 32, 93, 10.1016/j.riam.2014.06.005
Pamidimukkala, 2019, Mucormycosis due to Apophysomyces species complex- 25 years’ experience at a tertiary care hospital in southern India, Med Mycol, 10.1093/mmy/myz081
Rodríguez, 2017, Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient, Med Mycol Case Rep, 20, 4, 10.1016/j.mmcr.2017.12.002
Rammaert, 2012, Healthcare-associated mucormycosis, Clin Infect Dis, 54, S44, 10.1093/cid/cir867
Davoudi, 2015, Healthcare-associated outbreaks due to Mucorales and other uncommon fungi, Eur J Clin Invest, 45, 767, 10.1111/eci.12467
Kanamori, 2015, Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation, Clin Infect Dis, 61, 433, 10.1093/cid/civ297
Chakrabarti, 2010, Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern, J Clin Microbiol, 48, 4580, 10.1128/JCM.01420-10
Chamilos, 2006, Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003), Haematologica, 91, 986
Padhye, 1988, Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis, J Clin Microbiol, 26, 1861, 10.1128/JCM.26.9.1861-1863.1988
Chakrabarti, 2003, Apophysomyces elegans: an emerging zygomycete in India, J Clin Microbiol, 41, 783, 10.1128/JCM.41.2.783-788.2003
dela Cruz, 2012, Invasive Apophysomyces variabilis infection in a burn patient, J Clin Microbiol, 50, 2814, 10.1128/JCM.00671-12
Cornely, 2014, ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013, Clin Microbiol Infect, 2, 5, 10.1111/1469-0691.12371
Al-Zaydani, 2015, Aggressive cutaneous zygomycosis caused by Apophysomyces variabilis in an immunocompetent child, Med Mycol Case Rep, 10, 11, 10.1016/j.mmcr.2015.12.003
